Drugs / High Dose Methylprednisolone
last change Mar 2020 re-read 2 minutes ago

High Dose Methylprednisolone

Developed for
chronic lymphocytic leukemia/small lymphocytic lymphoma
Investigated by
Celgene Corporation · H. Lee Moffitt Cancer Center and Research Institute · Novartis

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01497496 Jan 2012 → Sep 2019 chronic lymphocytic leukemia/small lymphocytic lymphoma H. Lee Moffitt Cancer Center and Research Institute Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as High Dose Methylprednisolone ClinicalTrials.gov intervention name — accepted as the source's own label NCT01497496